(DBXA) Xtrackers MSCI Europe 1C - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0274209237
DBXA: Stocks, Shares, European, Large-Cap, Equity, Blend, Investments
The Xtrackers MSCI Europe UCITS ETF1C (XETRA:DBXA) is a Germany-originated ETF that tracks the Morningstar Developed Markets Europe TME NR EUR index, providing investors with exposure to large-cap European equities. As a blend equity ETF, it aims to replicate the performance of its underlying index, offering a diversified portfolio of European stocks.
Analyzing the ETFs technical data, we observe that the current price is €99.63, slightly above its 20-day simple moving average (SMA) of €99.01, indicating a potential bullish trend. The 50-day SMA (€95.06) and 200-day SMA (€93.23) are both below the current price, further supporting this trend. The average true range (ATR) is €0.91, representing a 0.92% daily price movement, suggesting moderate volatility. Given the current price is near its 52-week high (€100.04) and significantly above its 52-week low (€83.64), we can infer that the ETF has been performing well in the recent past.
From a fundamental perspective, the ETFs assets under management (AUM) stand at €3397.21 million, indicating a substantial investor base and liquidity. This sizeable AUM also suggests that the ETF is well-established and has a certain level of market presence.
Combining technical and fundamental insights, we can forecast that the Xtrackers MSCI Europe UCITS ETF1C may continue its upward trend, driven by its strong technical indicators and substantial AUM. However, its crucial to monitor the ETFs price movements in relation to its SMAs and ATR, as well as broader market conditions, to adjust investment strategies accordingly. A potential target price could be €102.00, representing a 2.4% increase from the current price, assuming the bullish trend persists.
Additional Sources for DBXA ETF
DBXA ETF Overview
Market Cap in USD | 6,787m |
Category | Europe Large-Cap Blend Equity |
TER | 0.12% |
IPO / Inception | 2007-01-10 |
DBXA ETF Ratings
Growth Rating | 71.6 |
Fundamental | - |
Dividend Rating | 2.39 |
Rel. Strength | -6.94 |
Analysts | - |
Fair Price Momentum | 94.35 EUR |
Fair Price DCF | - |
DBXA Dividends
Currently no dividends paidDBXA Growth Ratios
Growth Correlation 3m | 70.3% |
Growth Correlation 12m | 65.8% |
Growth Correlation 5y | 91.6% |
CAGR 5y | 11.00% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | 1.21 |
Alpha | -2.24 |
Beta | 0.541 |
Volatility | 12.29% |
Current Volume | 5.9k |
Average Volume 20d | 11.2k |
As of July 01, 2025, the stock is trading at EUR 97.46 with a total of 5,861 shares traded.
Over the past week, the price has changed by +1.06%, over one month by -1.24%, over three months by +2.64% and over the past year by +8.08%.
Yes. Based on ValueRay´s Analyses, Xtrackers MSCI Europe 1C (XETRA:DBXA) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 71.64 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBXA is around 94.35 EUR . This means that DBXA is currently overvalued and has a potential downside of -3.19%.
Xtrackers MSCI Europe 1C has no consensus analysts rating.
According to our own proprietary Forecast Model, DBXA Xtrackers MSCI Europe 1C will be worth about 106.4 in July 2026. The stock is currently trading at 97.46. This means that the stock has a potential upside of +9.21%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 106.4 | 9.2% |